Impact of a combination of pimobendan, furosemide, and enalapril on heart rate variability in naturally occurring, symptomatic, myxomatous mitral valve degeneration dogs

BACKGROUND: Pimobendan, diuretics, and an angiotensin-converting enzyme inhibitor (ACEi) are widely used for the management of chronic valvular heart disease in dogs; however, the effects of that combination on heart rate variability (HRV) are unknown. The purpose of this study was to assess the HRV...

Descripción completa

Detalles Bibliográficos
Autores principales: Pirintr, Prapawadee, Saengklub, Nakkawee, Boonpala, Pakit, Hamlin, Robert L., Kijtawornrat, Anusak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568857/
https://www.ncbi.nlm.nih.gov/pubmed/37821927
http://dx.doi.org/10.1186/s12917-023-03770-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568857/
https://www.ncbi.nlm.nih.gov/pubmed/37821927
http://dx.doi.org/10.1186/s12917-023-03770-6

Ejemplares similares